Package 69452-291-20

{"route": ["ORAL"], "spl_id": "a0977267-e400-48f6-99fa-dafcc483e96e", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "upc": ["0369452291306"], "unii": ["X4HES1O11F"], "rxcui": ["197311", "197313"], "spl_set_id": ["6f1db9f0-9b41-4fb7-8798-44fdc2c128df"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["Bionpharma Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (69452-291-20)", "package_ndc": "69452-291-20", "marketing_start_date": "20200815"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (69452-291-30)", "package_ndc": "69452-291-30", "marketing_start_date": "20200815"}], "brand_name": "Acyclovir", "product_id": "69452-291_a0977267-e400-48f6-99fa-dafcc483e96e", "dosage_form": "TABLET", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "69452-291", "generic_name": "Acyclovir", "labeler_name": "Bionpharma Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Acyclovir", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "800 mg/1"}], "application_number": "ANDA209366", "marketing_category": "ANDA", "marketing_start_date": "20200815", "listing_expiration_date": "20261231"}